The Asian Health Foundation is a non profit organization of leading medical experts dedicated to improving the health of Asian Americans & Pacific Islanders (AAPIs)

Upcoming Programs: Save the Date!

AHF – SaveTheDate v2 (003)

What’s new:

The Asian Health Foundation (AHF) is pleased to announce the establishment of the inaugural Professors Ramsey Cheung MD and Gabriel Garcia MD Travel Award for Africa (Travel Awards) under the Mindie H. Nguyen, MD Travel Awards Program. Funding for the inaugural Travel Awards was generously provided by a directed contribution by AHF Board Member, Mindie H. Nguyen, MD, in honor of Professors Ramsey Cheung and Gabriel Garcia for their life-long commitment and contribution to diversity, medical education and mentoring of generations of GI and hepatology trainees, including Dr. Nguyen.

The goal of the Mindie H. Nguyen Travel Awards Program is to encourage clinical hepatology research in viral hepatitis, fatty liver disease, or hepatocellular carcinoma by early career investigators in the Africa, Central or South America, Southeast Asia, and Western Pacific regions. These awards provide recipients travel support to defray costs associated with attending educational meetings to present their outstanding research to a national or international audience.

The Gastroenterology and Hepatology Association of sub-Saharan Africa (GHASSA) received the inaugural Travel Award to support attendance at the African Viral Hepatitis Conference in Cape Town from May 16-18, 2024.

On-Demand Programs

Overcoming HBV Barriers: Focus on Asian American People

Join expert faculty and patients to learn about and address barriers to HBV care in Asian American communities. Watch the on-demand videos, listen to the podcasts, download the slides, and read the ClinicalThought commentaries.

Link: https://clinicaloptions.com/CE-CME-program/hepatology/hbv-key-communities/17063?utm_source=partner&utm_medium=web&utm_campaign=id_hep_prp5676_ahf-program-promo_e&utm_content=&utm_term=

Educating Frontline Providers to Reduce Missed Opportunities for HBV Screening

Hepatitis B virus (HBV) is one of the leading causes of chronic liver disease, cirrhosis, and liver cancer in the United States, but HBV screening opportunities are often missed due to the bias, stigma, or knowledge deficits of health care professionals (HCPs) and the lack of linkage to care. Front-line HCPs, particularly in community-based settings, need education on universal screening practices as well as a multi-faceted approach for streamlining linkage to care, including cultural humility training to overcome barriers related to social determinants of health (SDoH).

In this recorded CME Outfitters webcast, expert faculty focus on universal HBV screening with triple panel testing to accurately identify patients with active HBV infection. The faculty also present strategies and best practices for linking patients with HBV to appropriate medical care based on interpretation of serological test results while factoring in SDoH.

Link: cmeo.me/WC064AHF

D Is for Diagnosis: The Case for Simplifying Viral Hepatitis Screening

Learn answers to key questions that can help you lessen the burden of hepatitis delta virus (HDV) infection:

What is the simplest way of effectively diagnosing hepatitis B virus (HBV) and considering treatment candidacy?

How can HDV screening be made an automatic part of the workflow of HBV screening in diverse healthcare settings?

What are the key next steps for patients diagnosed with HDV to ensure continued engagement in care?

Partnering With Patients: Overcoming Barriers to HBV Care in Asian Communities in the US

Join expert faculty and patients to learn about and address HBV misconceptions regarding HBV transmission, risk, and outcomes, cultural belief systems, mistrust, and stigma that can all hinder engagement in care in your community. Watch the on-demand webcasts, listen to the podcasts, and read the companion ClinicalThought commentaries.

Managing HCV: Tackling Tough Cases

This 3-part On-Demand series from CME Outfitters features expert faculty presenting patient case scenarios and sharing best practices for treating patients with HCV and CKD, mitigating progression of liver fibrosis in HIV/HCV coinfection, and selecting appropriate treatments in patients with decompensated cirrhosis. Start now and earn free CME/CE credit in minutes!

Addressing HBV Disparities and Stigma: Strategies to Manage Conversations with Your Clinician

Drs. Do and Nguyen provide useful information about hepatitis B infection including answers to common questions that patients have when they first receive a diagnosis, information about risk factors and misconceptions, and important steps patients can take to reduce the burden of the disease.

What is HDV?

Dr. Do and Dr. Gish explain hepatitis D infection for patients and answer common questions that patients have when they first receive a diagnosis. They also offer advice about how patients can lower the overall burden of disease.

AHF Online Hepatitis B Education Now Available!

Hepatitis B disproportionately affects Asian and Pacific Islander communities. Because currently available therapy can’t eradicate the hepatitis B virus (HBV), the objective of treatment is viral suppression. But many with chronic hepatitis B are unaware of their disease status, which can result in an increased likelihood of virus transmission and fewer treatment options with poorer outcomes. Experts in hepatitis B discuss the importance of testing for HBV and treatment of chronic hepatitis B so patients can “be there” for their families.

HBV Patient Education poster – Engl.Simp. Chin.Viet.Kor.